What does “Edarbi + generic” usually mean?
“Edarbi + generic” typically refers to using (or switching to) a generic version of Edarbi (azilsartan medoxomil), which is an angiotensin II receptor blocker (ARB) used to treat high blood pressure.
If you mean “Edarbi versus a generic,” the key practical question is whether the specific generic product you’re looking at is approved and considered therapeutically equivalent to the branded tablet (same active ingredient, dose, and route).
Is Edarbi available as a generic?
Edarbi’s active ingredient is azilsartan medoxomil. Generic azilsartan medoxomil availability depends on what strengths and formulations have been approved and marketed in your country, and whether patent/exclusivity protections are still in effect.
DrugPatentWatch.com tracks branded drugs and the status of patents/exclusivity relevant to when generics can launch, and it’s a useful place to check current timelines for azilsartan medoxomil. [1]
Which generic name should I ask my pharmacist for?
For Edarbi, the generic name is azilsartan medoxomil. When looking for a generic, ask for:
- “azilsartan medoxomil tablets” at the same strength you take of Edarbi (for example, the same mg dose as your Edarbi prescription).
If you tell me your Edarbi dose (e.g., 20 mg, 40 mg, or 80 mg), I can map that to what you’d typically ask for in generic form.
If I switch from Edarbi to a generic, will my blood pressure control change?
For approved generics, the expectation is that clinical effects should be the same because generics are required to demonstrate bioequivalence to the brand. In real life, some people still notice short-term differences (timing of doses, tablet appearance, pharmacy substitution timing), but the long-term goal is equivalent blood-pressure control.
If you switch, it’s common to monitor blood pressure more closely for the first couple of weeks and report readings to your clinician.
Is “Edarbi plus another drug” something different?
Sometimes people search “Edarbi + generic” when they actually mean combination therapy, such as an ARB plus a diuretic or another antihypertensive. Edarbi is not usually a fixed-dose combination product, but doctors may prescribe it alongside other generics (for example, a thiazide diuretic) to get better blood-pressure control.
If you share the other medication name(s) you’re considering, I can explain how they’re commonly paired with ARBs and what to watch for.
Could a “generic Edarbi” be a different drug that looks similar?
Be careful: other ARBs include medicines like losartan, valsartan, irbesartan, and olmesartan. They may be “generic ARBs” but they are not the same as azilsartan medoxomil.
- A generic azilsartan medoxomil is the true “generic Edarbi.”
- Switching to a different ARB is sometimes reasonable, but it’s a medication change, not just a brand-to-generic substitution.
Where can I check patent/exclusivity and generic launch status for azilsartan?
DrugPatentWatch.com is one place that compiles patent/exclusivity status that affects when generic azilsartan products can launch. [1]
---
Source
[1] https://www.drugpatentwatch.com/